Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer.
- Author:
Jeong Il YU
1
;
Doo Ho CHOI
;
Seung Jae HUH
;
Won PARK
;
Seok Jin NAM
;
Seok Won KIM
;
Jeong Eon LEE
;
Won Ho KIL
;
Young Hyuck IM
;
Jin Seok AHN
;
Yeon Hee PARK
Author Information
- Publication Type:Original Article
- Keywords: Adjuvant radiotherapy; Breast neoplasms; Local neoplasm recurrence; Proportion; Segmental mastectomy
- MeSH: Breast Neoplasms*; Female; Follow-Up Studies; Humans; Lymph Nodes; Mastectomy, Segmental*; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy*; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies
- From:Journal of Breast Cancer 2015;18(1):50-56
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The present study was conducted to investigate the proportion and clinical outcomes of breast cancer patients who did not receive postoperative radiotherapy (PORT) after breast-conserving surgery (BCS). METHODS: This retrospective study included all breast cancer patients received curative BCS without PORT between 2003 and 2013. In the PORT omission group, characteristics and local recurrence differences were compared between the recommended group and the refused group. To compare the local recurrence-free survival (LRFS) of the PORT omission group and the control group who received PORT, subjects were selected by using the pooled data of patients treated between 1994 and 2007. RESULTS: During the study period, 96 patients did not receive PORT among a total of 6,680 patients who underwent BCS. Therefore, the overall rate of PORT omission was 1.4%. Among the 96 patients, 20 were recommended for PORT omission (recommended group) and 76 refused PORT (refused group). The median follow-up period of all study participants was 19.3 months (range, 0.3-115.1 months). Patients in the recommended group were older (p=0.004), were more likely to be postmenopausal (p=0.013), and had more number of positive prognostic factors compared with the refused group. Overall, 12 cases of disease recurrence, including 11 cases of local recurrence, developed in the PORT-refused group. The LRFS of the PORT-omission group was significantly inferior to that of patients who received PORT after BCS (p<0.001). In the PORT-omission group, significant favorable prognostic factors for LRFS were having histologic grade 1 or 2 disease (p=0.023), having no axillary lymph node metastasis (p=0.039), receiving adjuvant endocrine therapy (p=0.046), and being in the recommended group (p=0.026). CONCLUSION: The rate of PORT omission in the present study is very low among women who underwent surgery compared to that of other studies worldwide. PORT omission is significantly related to a high local recurrence rate.
